WO2011163557A2 - Accumulation of omega-7 fatty acids in plant seeds - Google Patents
Accumulation of omega-7 fatty acids in plant seeds Download PDFInfo
- Publication number
- WO2011163557A2 WO2011163557A2 PCT/US2011/041759 US2011041759W WO2011163557A2 WO 2011163557 A2 WO2011163557 A2 WO 2011163557A2 US 2011041759 W US2011041759 W US 2011041759W WO 2011163557 A2 WO2011163557 A2 WO 2011163557A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plant
- plant material
- acp
- seq
- fatty acids
- Prior art date
Links
- 238000009825 accumulation Methods 0.000 title description 42
- 235000021354 omega 7 monounsaturated fatty acids Nutrition 0.000 title description 35
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 114
- 229930195729 fatty acid Natural products 0.000 claims abstract description 114
- 239000000194 fatty acid Substances 0.000 claims abstract description 114
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 111
- 238000000034 method Methods 0.000 claims abstract description 82
- 230000001965 increasing effect Effects 0.000 claims abstract description 60
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 60
- 239000000463 material Substances 0.000 claims abstract description 48
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 46
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 46
- 230000014509 gene expression Effects 0.000 claims abstract description 45
- 241000196324 Embryophyta Species 0.000 claims description 185
- 108090000623 proteins and genes Proteins 0.000 claims description 47
- 241000219194 Arabidopsis Species 0.000 claims description 26
- LWTDZKXXJRRKDG-KXBFYZLASA-N (-)-phaseollin Chemical compound C1OC2=CC(O)=CC=C2[C@H]2[C@@H]1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-KXBFYZLASA-N 0.000 claims description 24
- 102000004190 Enzymes Human genes 0.000 claims description 24
- 108090000790 Enzymes Proteins 0.000 claims description 24
- 230000001105 regulatory effect Effects 0.000 claims description 23
- 150000001413 amino acids Chemical group 0.000 claims description 19
- 230000001629 suppression Effects 0.000 claims description 14
- 125000003729 nucleotide group Chemical group 0.000 claims description 13
- 101710163504 Phaseolin Proteins 0.000 claims description 12
- 239000002773 nucleotide Substances 0.000 claims description 12
- LWTDZKXXJRRKDG-UHFFFAOYSA-N phaseollin Natural products C1OC2=CC(O)=CC=C2C2C1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-UHFFFAOYSA-N 0.000 claims description 12
- 230000035772 mutation Effects 0.000 claims description 10
- 230000001131 transforming effect Effects 0.000 claims description 9
- 244000105624 Arachis hypogaea Species 0.000 claims description 7
- 230000003247 decreasing effect Effects 0.000 claims description 7
- 244000075850 Avena orientalis Species 0.000 claims description 6
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 6
- 241000208125 Nicotiana Species 0.000 claims description 6
- 240000006394 Sorghum bicolor Species 0.000 claims description 5
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 5
- 235000021307 Triticum Nutrition 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 235000001014 amino acid Nutrition 0.000 claims description 5
- 240000002791 Brassica napus Species 0.000 claims description 4
- 240000001689 Cyanthillium cinereum Species 0.000 claims description 4
- 241000209219 Hordeum Species 0.000 claims description 4
- 235000003846 Ricinus Nutrition 0.000 claims description 4
- 241000322381 Ricinus <louse> Species 0.000 claims description 4
- 241000209056 Secale Species 0.000 claims description 4
- 235000003911 Arachis Nutrition 0.000 claims description 3
- 239000004475 Arginine Substances 0.000 claims description 3
- 235000005781 Avena Nutrition 0.000 claims description 3
- 241000722877 Borago Species 0.000 claims description 3
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 claims description 3
- 235000006008 Brassica napus var napus Nutrition 0.000 claims description 3
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 claims description 3
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 claims description 3
- 241000208809 Carthamus Species 0.000 claims description 3
- 235000003901 Crambe Nutrition 0.000 claims description 3
- 241000220246 Crambe <angiosperm> Species 0.000 claims description 3
- 241000219992 Cuphea Species 0.000 claims description 3
- 241000512897 Elaeis Species 0.000 claims description 3
- 235000001942 Elaeis Nutrition 0.000 claims description 3
- 239000004471 Glycine Substances 0.000 claims description 3
- 241000219146 Gossypium Species 0.000 claims description 3
- 235000009438 Gossypium Nutrition 0.000 claims description 3
- 241000208818 Helianthus Species 0.000 claims description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 3
- 241000208204 Linum Species 0.000 claims description 3
- 241000219925 Oenothera Species 0.000 claims description 3
- 241000795633 Olea <sea slug> Species 0.000 claims description 3
- 241000209094 Oryza Species 0.000 claims description 3
- 241000390166 Physaria Species 0.000 claims description 3
- 241000209504 Poaceae Species 0.000 claims description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 3
- 241000862632 Soja Species 0.000 claims description 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 3
- 239000004473 Threonine Substances 0.000 claims description 3
- 241000209140 Triticum Species 0.000 claims description 3
- 241000208241 Tropaeolum Species 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 3
- 235000018417 cysteine Nutrition 0.000 claims description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 3
- 241001072282 Limnanthes Species 0.000 claims description 2
- 244000188595 Brassica sinapistrum Species 0.000 claims 2
- 241000219161 Theobroma Species 0.000 claims 2
- 241000209149 Zea Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 18
- 239000000203 mixture Substances 0.000 abstract description 5
- 108010036419 acyl-(acyl-carrier-protein)desaturase Proteins 0.000 abstract 4
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 61
- 235000004443 Ricinus communis Nutrition 0.000 description 31
- 210000001519 tissue Anatomy 0.000 description 28
- 230000009261 transgenic effect Effects 0.000 description 27
- 108050003185 3-oxoacyl-[acyl-carrier-protein] synthase 2 Proteins 0.000 description 20
- 239000000758 substrate Substances 0.000 description 16
- 108020004414 DNA Proteins 0.000 description 13
- 230000009466 transformation Effects 0.000 description 13
- 210000002706 plastid Anatomy 0.000 description 12
- 108091028043 Nucleic acid sequence Proteins 0.000 description 11
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 10
- 230000037353 metabolic pathway Effects 0.000 description 9
- 239000013612 plasmid Substances 0.000 description 9
- 240000008042 Zea mays Species 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000012269 metabolic engineering Methods 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- 238000013459 approach Methods 0.000 description 7
- 229910052799 carbon Inorganic materials 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 230000001404 mediated effect Effects 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 230000008929 regeneration Effects 0.000 description 7
- 238000011069 regeneration method Methods 0.000 description 7
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 6
- 230000000692 anti-sense effect Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 238000013518 transcription Methods 0.000 description 6
- 230000035897 transcription Effects 0.000 description 6
- 101100119780 Arabidopsis thaliana FATB gene Proteins 0.000 description 5
- 241000701489 Cauliflower mosaic virus Species 0.000 description 5
- -1 FA fatty acids Chemical class 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- 244000068988 Glycine max Species 0.000 description 5
- 101100119784 Umbellularia californica FATB1 gene Proteins 0.000 description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000001488 breeding effect Effects 0.000 description 5
- 230000004186 co-expression Effects 0.000 description 5
- 235000005822 corn Nutrition 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 241000589158 Agrobacterium Species 0.000 description 4
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 4
- 235000010777 Arachis hypogaea Nutrition 0.000 description 4
- 241001071161 Asclepias Species 0.000 description 4
- 244000299507 Gossypium hirsutum Species 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 4
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 230000007306 turnover Effects 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- 235000017060 Arachis glabrata Nutrition 0.000 description 3
- 235000018262 Arachis monticola Nutrition 0.000 description 3
- 235000007319 Avena orientalis Nutrition 0.000 description 3
- 241000219198 Brassica Species 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 3
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 3
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 241000736122 Parastagonospora nodorum Species 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- 101710154134 Stearoyl-[acyl-carrier-protein] 9-desaturase, chloroplastic Proteins 0.000 description 3
- 244000098338 Triticum aestivum Species 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 210000002257 embryonic structure Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000004907 flux Effects 0.000 description 3
- 239000005090 green fluorescent protein Substances 0.000 description 3
- 239000004009 herbicide Substances 0.000 description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 229940049964 oleate Drugs 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 235000020232 peanut Nutrition 0.000 description 3
- 150000003904 phospholipids Chemical class 0.000 description 3
- 238000003976 plant breeding Methods 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 108010054624 red fluorescent protein Proteins 0.000 description 3
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 3
- 229960003656 ricinoleic acid Drugs 0.000 description 3
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000009897 systematic effect Effects 0.000 description 3
- 230000002103 transcriptional effect Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 241000351920 Aspergillus nidulans Species 0.000 description 2
- 208000016444 Benign adult familial myoclonic epilepsy Diseases 0.000 description 2
- 235000011331 Brassica Nutrition 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 2
- 240000004585 Dactylis glomerata Species 0.000 description 2
- 102000036181 Fatty Acid Elongases Human genes 0.000 description 2
- 108010058732 Fatty Acid Elongases Proteins 0.000 description 2
- 241000234643 Festuca arundinacea Species 0.000 description 2
- 241000701484 Figwort mosaic virus Species 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 240000004658 Medicago sativa Species 0.000 description 2
- 238000000636 Northern blotting Methods 0.000 description 2
- 108091030071 RNAI Proteins 0.000 description 2
- 240000000528 Ricinus communis Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 108010016634 Seed Storage Proteins Proteins 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- 102000005488 Thioesterase Human genes 0.000 description 2
- 108091036066 Three prime untranslated region Proteins 0.000 description 2
- 235000007244 Zea mays Nutrition 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000002869 basic local alignment search tool Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 238000013375 chromatographic separation Methods 0.000 description 2
- 239000005516 coenzyme A Substances 0.000 description 2
- 229940093530 coenzyme a Drugs 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 241001233957 eudicotyledons Species 0.000 description 2
- 208000016427 familial adult myoclonic epilepsy Diseases 0.000 description 2
- 230000004136 fatty acid synthesis Effects 0.000 description 2
- ZGNITFSDLCMLGI-UHFFFAOYSA-N flubendiamide Chemical compound CC1=CC(C(F)(C(F)(F)F)C(F)(F)F)=CC=C1NC(=O)C1=CC=CC(I)=C1C(=O)NC(C)(C)CS(C)(=O)=O ZGNITFSDLCMLGI-UHFFFAOYSA-N 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 230000009368 gene silencing by RNA Effects 0.000 description 2
- 230000002363 herbicidal effect Effects 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 108010053156 lipid transfer protein Proteins 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 108010083942 mannopine synthase Proteins 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 108010058731 nopaline synthase Proteins 0.000 description 2
- 230000008635 plant growth Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 108020002982 thioesterase Proteins 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 102100031251 1-acylglycerol-3-phosphate O-acyltransferase PNPLA3 Human genes 0.000 description 1
- 108010054662 2-acylglycerophosphate acyltransferase Proteins 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- 108020005345 3' Untranslated Regions Proteins 0.000 description 1
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
- 108020003589 5' Untranslated Regions Proteins 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-M 9-cis,12-cis-Octadecadienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O OYHQOLUKZRVURQ-HZJYTTRNSA-M 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 101710146995 Acyl carrier protein Proteins 0.000 description 1
- 240000007241 Agrostis stolonifera Species 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 235000007689 Borago officinalis Nutrition 0.000 description 1
- 240000004355 Borago officinalis Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 240000000385 Brassica napus var. napus Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N C1CCCCC1 Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- QCMYYKRYFNMIEC-UHFFFAOYSA-N COP(O)=O Chemical class COP(O)=O QCMYYKRYFNMIEC-UHFFFAOYSA-N 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 108010004539 Chalcone isomerase Proteins 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- 101710195281 Chlorophyll a-b binding protein Proteins 0.000 description 1
- 101710143415 Chlorophyll a-b binding protein 1, chloroplastic Proteins 0.000 description 1
- 101710181042 Chlorophyll a-b binding protein 1A, chloroplastic Proteins 0.000 description 1
- 101710091905 Chlorophyll a-b binding protein 2, chloroplastic Proteins 0.000 description 1
- 101710095244 Chlorophyll a-b binding protein 3, chloroplastic Proteins 0.000 description 1
- 101710127489 Chlorophyll a-b binding protein of LHCII type 1 Proteins 0.000 description 1
- 101710184917 Chlorophyll a-b binding protein of LHCII type I, chloroplastic Proteins 0.000 description 1
- 101710102593 Chlorophyll a-b binding protein, chloroplastic Proteins 0.000 description 1
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 241000723221 Crepis Species 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 102000002148 Diacylglycerol O-acyltransferase Human genes 0.000 description 1
- 108010001348 Diacylglycerol O-acyltransferase Proteins 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 102000005289 Eukaryotic Initiation Factor-4A Human genes 0.000 description 1
- 108010056472 Eukaryotic Initiation Factor-4A Proteins 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 101150115493 FAD3 gene Proteins 0.000 description 1
- 108010087894 Fatty acid desaturases Proteins 0.000 description 1
- 102000009114 Fatty acid desaturases Human genes 0.000 description 1
- 108700037728 Glycine max beta-conglycinin Proteins 0.000 description 1
- 101710115777 Glycine-rich cell wall structural protein 2 Proteins 0.000 description 1
- 101710168683 Glycine-rich protein 1 Proteins 0.000 description 1
- 239000005562 Glyphosate Substances 0.000 description 1
- 235000009432 Gossypium hirsutum Nutrition 0.000 description 1
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- 241000134253 Lanka Species 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 241000228456 Leptosphaeria Species 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- 241000208202 Linaceae Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 235000010624 Medicago sativa Nutrition 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101710202365 Napin Proteins 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108090000913 Nitrate Reductases Proteins 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 101710089395 Oleosin Proteins 0.000 description 1
- 108010035473 Palmitoyl-CoA Hydrolase Proteins 0.000 description 1
- 102000008172 Palmitoyl-CoA Hydrolase Human genes 0.000 description 1
- 101710091688 Patatin Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 240000007377 Petunia x hybrida Species 0.000 description 1
- 108700011203 Phaseolus vulgaris phaseolin Proteins 0.000 description 1
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N Phosphinothricin Natural products CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 1
- 241000209049 Poa pratensis Species 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 108020004412 RNA 3' Polyadenylation Signals Proteins 0.000 description 1
- 102000009572 RNA Polymerase II Human genes 0.000 description 1
- 108010009460 RNA Polymerase II Proteins 0.000 description 1
- 230000004570 RNA-binding Effects 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 241000209051 Saccharum Species 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000007230 Sorghum bicolor Nutrition 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 241000044578 Stenotaphrum secundatum Species 0.000 description 1
- 108010043934 Sucrose synthase Proteins 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 235000004424 Tropaeolum majus Nutrition 0.000 description 1
- 240000001260 Tropaeolum majus Species 0.000 description 1
- 101710162629 Trypsin inhibitor Proteins 0.000 description 1
- 229940122618 Trypsin inhibitor Drugs 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 244000025271 Umbellularia californica Species 0.000 description 1
- 101710110895 Uncharacterized 7.3 kDa protein in cox-rep intergenic region Proteins 0.000 description 1
- 235000021322 Vaccenic acid Nutrition 0.000 description 1
- UWHZIFQPPBDJPM-FPLPWBNLSA-M Vaccenic acid Natural products CCCCCC\C=C/CCCCCCCCCC([O-])=O UWHZIFQPPBDJPM-FPLPWBNLSA-M 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- 108010055615 Zein Proteins 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 108010056748 acetylenase Proteins 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 108700021044 acyl-ACP thioesterase Proteins 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 150000008331 benzenesulfonamides Chemical class 0.000 description 1
- GINJFDRNADDBIN-FXQIFTODSA-N bilanafos Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCP(C)(O)=O GINJFDRNADDBIN-FXQIFTODSA-N 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 238000010256 biochemical assay Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004883 computer application Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- NAGJZTKCGNOGPW-UHFFFAOYSA-N dithiophosphoric acid Chemical class OP(O)(S)=S NAGJZTKCGNOGPW-UHFFFAOYSA-N 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 230000001424 embryocidal effect Effects 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 108010017796 epoxidase Proteins 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 150000002190 fatty acyls Chemical group 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 230000004545 gene duplication Effects 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 description 1
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 1
- 229940097068 glyphosate Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229940030980 inova Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- 125000005481 linolenic acid group Chemical group 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 239000003147 molecular marker Substances 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 230000031787 nutrient reservoir activity Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 150000008298 phosphoramidates Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000004069 plant analysis Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000012846 protein folding Effects 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- 238000009394 selective breeding Methods 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000014639 sexual reproduction Effects 0.000 description 1
- 244000000000 soil microbiome Species 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 108010032326 thioesterase II Proteins 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- UWHZIFQPPBDJPM-BQYQJAHWSA-N trans-vaccenic acid Chemical compound CCCCCC\C=C\CCCCCCCCCC(O)=O UWHZIFQPPBDJPM-BQYQJAHWSA-N 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 1
- 229960001082 trimethoprim Drugs 0.000 description 1
- MDTPTXSNPBAUHX-UHFFFAOYSA-M trimethylsulfanium;hydroxide Chemical compound [OH-].C[S+](C)C MDTPTXSNPBAUHX-UHFFFAOYSA-M 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
- C12N15/823—Reproductive tissue-specific promoters
- C12N15/8234—Seed-specific, e.g. embryo, endosperm
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0083—Miscellaneous (1.14.99)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/19—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water (1.14.19)
- C12Y114/19001—Stearoyl-CoA 9-desaturase (1.14.19.1), i.e. DELTA9-desaturase
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Definitions
- the invention relates to a novel mutant Ricinus
- a 9 -18:0-ACP desaturase designated Com25, that functions as a A 9 -16:0-ACP desaturase.
- Another embodiment relates to methods of metabolic engineering to manipulate metabolic branch points in plants, for example, to redirect carbon into ⁇ -7 fatty acids.
- the invention relates to methods for expressing Com25 as part of a metabolic engineering strategy, such that carbon is redirected into ⁇ -7 fatty acids in plant seeds.
- nucleotide sequences encoding a novel variant desaturase designated Com25, and the amino acid sequence thereof.
- the methods include expressing Com25 in Arabidopsis.
- the unusual fatty acids increased in plant seeds are ⁇ -7 fatty acids.
- the co-7 fatty acids may be 16:1 ⁇ 19 and/or 18:1 ⁇ ⁇ .
- Methods are also provided for expressing Com25 in a plant cell, wherein the plant cell is impaired in plastidial and extraplastidial fatty acid elongation, such that the percent composition of unusual fatty acids in plant seeds is increased.
- the methods include expressing Com25 in Arabidopsis.
- the unusual fatty acids increased in plant seeds are co-7 fatty acids.
- the ⁇ -7 fatty acids may be 16:1 ⁇ 19 and/or 18: 1 ⁇ 1 ! .
- the methods include expressing Com25 in Arabidopsis.
- the unusual fatty acids increased in plant seeds are co-7 fatty acids.
- the co-7 fatty acids may be 16:1 ⁇ 19 and/or 18: 1 ⁇ ⁇ .
- Methods are also provided for expressing Com25 in a plant cell wherein KASII and plastidial and extraplastidial fatty acid elongation are inhibited in the plant cell, such that the percent composition of unusual fatty acids in plant seeds is increased.
- the methods include expressing Com25 in Arabidopsis.
- the unusual fatty acids increased in plant seeds are co-7 fatty acids.
- the co-7 fatty acids may be 16:1 ⁇ 19 and/or 18:1 ⁇ ⁇ .
- FIG. 1 depicts a schematic of fatty acid synthesis and modification in the plastid and endoplasmic reticulum of Arabidopsis. Reactions mediated by 16:0 desaturases are indicated 1 : A 9 -16:0-ACP desaturase; 2: extraplastidial A 9 -16:0-ACP desaturase. ⁇ -7 FA, i.e., 16:1 ⁇ 9 and 18:1 ⁇ 11 are boxed.
- FIG. 2 displays a representative gas chromatographic separation of FAMEs upon expression of Com25 in various backgrounds of Arabidopsis.
- Panels A and B WT; C and O,fabl; E and V,fabllfael.
- Panels A, C and E untransformed; B, D and F, transformed with Phas:Com25.
- FAME peaks are indicated: 16:0 (1), 16:1A 9 (2), 16:2 (3), 18:0 (4), 18:1 A 9 (5), 18:1 ⁇ ⁇ (6), 18:2 (7), 20:0 (8), 20:1 ⁇ ⁇ (6), 18:2 (7), 20:0 (8), 20:1 ⁇ ⁇ (9), 18:3+20: 1 ⁇ 13 (10), and 22: 1 (11).
- FIG. 3 shows the relationship between 16:0 in host seeds versus co-7 accumulation (as mol percent).
- FIG. 4 displays a representative gas chromatographic separation of FAMEs upon expression of Com25 in various backgrounds or Arabidopsis.
- Panel A best fabl/fael, P as:Com25, Fabl-H? AS, AnA9DS, LnA9DS transformant line;
- Panel B Doxantha seed. Peak designations are as described in FIG. 2.
- FIG. 5 is a schematic arrangement of DNA elements in particular construct embodiments of the invention. MODE(S) FOR CARRYING OUT THE INVENTION
- nucleotide acid molecules encoding a ⁇ 9 desaturase enzyme comprising a nucleotide sequence at least 60% identical to SEQ ID NO: 1.
- the nucleic acid molecules may further comprise a gene regulatory element.
- the gene regulatory element may be a phaseolin promoter.
- ⁇ 9 desaturase enzymes comprising an amino acid sequence at least 80% identical to SEQ ID NO:2.
- ⁇ 9 desaturase enzymes of the present invention wherein the amino acid sequence is at least 80% identical to SEQ ID NO:2 may further comprise a serine at the position analogous to position 114 in SEQ ID NO:2; an arginine at the position analogous to position 117 in SEQ ID NO:2; a cysteine at the position analogous to position 118 in SEQ ID NO:2, a leucine at the position analogous to position 179 in SEQ ID NO:2; and/or a threonine at the position analogous to position 188 in SEQ ID NO:2.
- Nucleic acid molecules and ⁇ 9 desaturase enzymes of the present invention may be expressed in plant materials, cells, tissues, or whole plants, to increase the amount of unusual fatty acids in the plant material, cells, tissues, or whole plants, relative to the amount observed in a wild type plant of the same species.
- Alternative embodiments of the invention include methods for increasing the amount of unusual fatty acids in the plant material, cells, tissues, or whole plants comprising transforming plant material, cells, tissues, or whole plants with the nucleic acid molecule of SEQ ID NO:l, such that the amount of unusual fatty acids in said plant material, cells, tissues, or whole plants is increased.
- the plant material, cells, tissues, or whole plants that are transformed by the disclosed methods further comprise one or more means for increasing levels of 16:0-ACP in the plant material, cells, tissues, or whole plants.
- the means for increasing the levels of 16:0-ACP in the plant material, cells, tissues, or whole plants may be: expression of an extraplastidial desaturase; suppression of KASII, for example by introducing a mutation in the fabl gene; and/or decreasing the elongation of 16:0 fatty acids, for example by introducing a mutation in the fael gene.
- Disclosed methods herein may be performed, for example, on plants, or plant materials derived from plants, of the genus Arabidopsis.
- a particular embodiment is drawn to methods for creating or regenerating a genetically engineered plant comprising increased amounts of unusual fatty acids in the plant compared to a wild type plant of the same species, comprising transforming plant material with nucleic acid molecule of SEQ ID NO: 1 ; and culturing the transformed plant material to obtain a plant. Plants, plant materials, plant cells, and seeds obtained by the aforementioned methods are also disclosed. II. Abbreviations
- Fatty acid refers to long chain aliphatic acids (alkanoic acids) of varying chain lengths, from about C12 to C22, although both longer and shorter chain-length acids are known.
- the structure of a fatty acid is represented by the notation, ⁇ : ⁇ ⁇ , where "x" is the total number of carbon (C) atoms in the particular fatty acid, and “y” is the number of double bonds in the carbon chain in the position "z,” as counted from the carboxyl end of the acid.
- Unusual fatty acid For the purposes of the present invention, unusual fatty acids are those whose synthesis in natural systems is initiated by modification of an intermediate of FAS by a variant desaturase enzyme.
- Metabolic pathway refers to a series of chemical reactions occurring within a cell, catalyzed by enzymes, to achieve either the formation of a metabolic product, or the initiation of another metabolic pathway.
- a metabolic pathway may involve several or many steps, and may compete with a different metabolic pathway for specific reaction substrates.
- the product of one metabolic pathway may be a substrate for yet another metabolic pathway.
- Metabolic engineering refers to the rational design of strategies to alter one or more metabolic pathways in a cell, such that the step-by-step modification of an initial substance into a product having the exact chemical structure desired is achieved within the overall scheme of the total metabolic pathways operative in the cell.
- Desaturase refers to a polypeptide that can desaturate (i.e., introduce a double bond) in one or more fatty acids to produce a fatty acid or precursor of interest.
- Plant-soluble fatty acid desaturase enzymes introduce a double bond regiospecifically into a saturated acyl-ACP substrate. The reaction involves activation of molecular oxygen by a two-electron reduced diiron center coordinated by a four-helix bundle that forms the core of the desaturase architecture.
- ⁇ 9 desaturases are particularly interest herein.
- the A 9 -18:0 1 -ACP desaturase is required by all plants for the maintenance of membrane fluidity. While this enzyme primarily desaturates stearoyl-ACP, it is also active to a minor extent with palmitoyl-ACP.
- variant desaturase encompasses those desaturases that exhibit specific activity profiles consistent with a role in producing unusual fatty acids.
- a variant desaturase may be isolated from an organism, or engineered via a directed evolution program.
- Progeny plant refers to any plant, or plant material obtained therefrom, that may be obtained by plant breeding methods. Plant breeding methods are well-known in the art, and include natural breeding, artificial breeding, selective breeding involving DNA molecular marker analysis, transgenics, and commercial breeding.
- Plant material refers to any cell or tissue obtained from a plant.
- Nucleic acid molecule A polymeric form of nucleotides, which can include both sense and anti-sense strands of RNA, cDNA, genomic DNA, and synthetic forms and mixed polymers of the above.
- a nucleotide refers to a ribonucleotide
- nucleic acid molecule as used herein is synonymous with “nucleic acid” and “polynucleotide.” The term includes single- and double-stranded forms of DNA.
- a nucleic acid molecule can include either or both naturally occurring and modified nucleotides linked together by naturally occurring and/or non-naturally occurring nucleotide linkages.
- Nucleic acid molecules can be modified chemically or biochemically, or can contain non-natural or derivatized nucleotide bases, as will be readily appreciated by those of ordinary skill in the art. Such modification include, for example, labels, methylation, substitution of one or more of the naturally occurring nucleotides with an analog, internucleotide modifications, such as uncharged linkages (for example, methyl phosphonates, phosphotnesters, phosphoramidates, carbamates, etc.), charged linkages (for example, phosphorothioates, phosphorodithioates, etc.), pendent moieties (for example, peptides), intercalators (for example, acridine, psoralen, etc.), chelators, alkylators, and modified linkages (for example, alpha anomeric nucleic acids, etc.).
- the term "nucleic acid molecule” also includes any topological conformation, including single-stranded, double-stranded, partially duplex
- a first nucleic acid sequence is operably linked with a second nucleic acid sequence when the first nucleic acid sequence is in a functional relationship with the second nucleic acid sequence.
- a promoter is operably linked to a coding sequence if the promoter affects the transcription or expression of the coding sequence.
- operably linked nucleic acid sequences are generally contiguous and, where necessary to join two protein-coding regions, in the same reading frame. However, nucleic acids need not be contiguous to be operably linked.
- regulatory element refers to a nucleic acid molecule having gene regulatory activity; i.e., one that has the ability to affect the transcription or translation of an operably linked transcribable nucleic acid molecule. Regulatory elements such as promoters, leaders, introns, and transcription termination regions are non-coding nucleic acid molecules having gene regulatory activity which play an integral part in the overall expression of genes in living cells. Isolated regulatory elements that function in plants are therefore useful for modifying plant phenotypes through the techniques of molecular engineering. By “regulatory element,” it is intended a series of nucleotides that determines if, when, and at what level a particular gene is expressed. The regulatory DNA sequences specifically interact with regulatory proteins or other proteins.
- gene regulatory activity refers to a nucleic acid molecule capable of affecting transcription or translation of an operably linked nucleic acid molecule.
- An isolated nucleic acid molecule having gene regulatory activity may provide temporal or spatial expression or modulate levels and rates of expression of the operably linked nucleic acid molecule.
- An isolated nucleic acid molecule having gene -Si- regulatory activity may comprise a promoter, intron, leader, or 3' transcriptional termination region.
- Promoters refers to a nucleic acid molecule that is involved in recognition and binding of RNA polymerase II or other proteins such as transcription factors (trans-acting protein factors that regulate transcription) to initiate transcription of an operably linked gene. Promoters may themselves contain sub-elements such as cis-elements or enhancer domains that effect the transcription of operably linked genes.
- a “plant promoter” is a native or non-native promoter that is functional in plant cells. A plant promoter can be used as a 5' regulatory element for modulating expression of an operably linked gene or genes.
- Plant promoters may be defined by their temporal, spatial, or developmental expression pattern.
- the nucleic acid molecules described herein may comprise nucleic acid sequences comprising promoters.
- Sequence identity The similarity between two nucleic acid sequences or between two amino acid sequences is expressed in terms of the level of sequence identity shared between the sequences. Sequence identity is typically expressed in terms of percentage identity; the higher the percentage, the more similar the two sequences. Methods for aligning sequences for comparison are described in detail below.
- Analogous position in an amino acid sequence Nucleic acid and amino acid sequences may be aligned by the methods described in the following paragraphs. When aligned, a position in one sequence is in "an analogous position" with a position in the aligned sequence if the positions are identical within the consensus sequence.
- NCBI National Center for Biotechnology Information
- BLAST Basic Local Alignment Search Tool
- blast.ncbi.nlm.nih.gov/Blast.cgi for use in connection with sequence-analysis programs, for example, blastp and blastn.
- sequence-analysis programs for example, blastp and blastn.
- a description of how to determine sequence identity using this program is available on the Internet through NCBI at
- the "Blast 2 sequences" function of the BLAST program (bl2seq) is employed using the default parameters. Specific parameters may be adjusted within the discretion of one of skill in the art, to for example, provide a penalty for a mismatch or reward for a match.
- transformed refers to a cell, tissue, organ, or organism into which has been introduced a foreign nucleic acid molecule, such as a construct.
- the introduced nucleic acid molecule may be integrated into the genomic DNA of the recipient cell, tissue, organ, or organism such that the introduced polynucleotide molecule is inherited by subsequent progeny.
- a "transgenic” or “transformed” cell or organism also includes progeny of the cell or organism and progeny produced from a breeding program employing such a transgenic plant as a parent in, for example, a cross and exhibiting an altered phenotype resulting from the presence of a foreign nucleic acid molecule.
- An embodiment of the invention includes a systematic approach to metabolic engineering the accumulation of co-7 fatty acids (FA), comprised of palmitoleic (16:1 ⁇ 9 ) and vaccenic acid (18:1 ⁇ ⁇ ), for example, in plant seeds.
- FA co-7 fatty acids
- Com25 a 16:0-ACP desaturase resulting from a directed evolution program to enhance the 16:0-desaturase activity of the castor A 9 -18:0-desaturase, was expressed under the control of the seed-specific phaseolin promoter. Any seed-specific promoter may be used in the embodiments disclosed herein.
- This approach increased the accumulation of ⁇ -7 FA from less than 2% in wild type (WT) to about 14% in Com25 transformants.
- phaseolin:Com25 construct was expressed in a series of KASII-deficient backgrounds and ⁇ -7 FA content increasing proportionately with 16:0 content up to about 30% with total ⁇ -7 FA accumulation up to about 55% was observed.
- transgenics accumulating 56% ⁇ -7 FA still contained about 19% 16:0, more than twice that of WT plants.
- Expression of extraplastidial 16:0 desaturases to intercept the flux of 16:0 en route to triacylglycerol was investigated. Co-expression of plastidial and
- extraplastidial desaturases along with suppression of KASII in the fabllfael double mutant background resulted in increased accumulation of ⁇ -7 FA from about 2% in WT to about 71%) in the best engineered line, equivalent to that found in Doxantha seeds.
- ⁇ -7 FAs were selected as the target because their synthesis in natural systems, like those of other unusual FA, is initiated by modification of an intermediate of FAS by a variant desaturase enzyme. Cahoon et al, (1997) Plant Mol. Biol. 33:1105-10; and Cahoon et al, (1998) Plant Physiol. 117(2):593-8.
- ⁇ -7 FA have potential commercial applications as polymer feedstocks while having similar physical properties to naturally occurring unsaturated fatty acids.
- Metabolic engineering studies were initiated by introducing a previously unreported A 9 -16:0-acyl carrier protein (ACP) desaturase, Com25, into the model plant Arabidopsis under the control of a seed-specific promoter. Approaches to diverting carbon flow into ⁇ -7 FA by the choice of mutant backgrounds that contain elevated levels of 16:0 and by the co-expression of constructs designed to divert the flux of carbon into the target fatty acid by affecting competition for substrate were explored. Extraplastidial desaturase enzymes were expressed to desaturate residual 16:0 after export from the plastid.
- ACP acyl carrier protein
- 16:0-ACP the precursor of ⁇ -7 fatty acids
- 16:0-ACP the precursor of ⁇ -7 fatty acids
- Suppression of KASII and FATB are effective ways to reduce competition for substrate and increase the accumulation of ⁇ -7 FA.
- the increase in co-7 FA accumulation is saturable at about 30% in the host line, because above this level the desaturase is limiting.
- Increasing the dosage of Com25 by expressing a second copy under the control of a seed-specific promoter further increased the accumulation of ⁇ -7 fatty acids.
- the seeds of high ⁇ -7 FA accumulators also contained levels of 16:0 in the range of about 20%), presenting an opportunity to desaturate extraplastidial 16:0.
- Expression of two extraplastidial desaturases increased the accumulation of ⁇ -7 FA, resulting in an approximately 50%> decrease of 16:0 in mature seeds.
- Nucleic acid sequences in some embodiments of the present invention show increasing percentage identities when aligned with SEQ ID NO: 1.
- Specific nucleic acid sequences within these and other embodiments may comprise sequences having, for example, at least 60%, 65%, 70%, 75%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95% 96%, 97%, 98%, or 100% identity with SEQ ID NO:2. It is understood by those of ordinary skill in the art that nucleic acid molecules may be modified without substantially changing the amino acid sequence of an encoded polypeptide, for example, according to permissible nucleotide substitutions according to codon degeneracy.
- nucleic acid molecules of the present invention comprise promoters.
- Promoters may be selected on the basis of the cell type into which the vector construct will be inserted. Promoters which function in bacteria, yeast, and plants are well-known in the art. The promoters may also be selected on the basis of their regulatory features. Examples of such features include enhancement of transcriptional activity, inducibility, tissue-specificity, and developmental
- promoters that are inducible, of viral or synthetic origin, constitutively active, temporally regulated, and spatially regulated have been described (For example, see Poszkowski, et al, (1989) EMBO J. 3:2719; Odell et al, (1985) Nature 313:810; Chau et al, (1989) Science 244:174-81).
- constitutive promoters include, for example, the CaMV 35S promoter, the enhanced CaMV 35S promoter, the Figwort Mosaic Virus promoter, the mannopine synthase promoter, the nopaline synthase promoter, and the octopine synthase promoter.
- Useful inducible promoters include, for example, promoters induced by salicylic acid or polyacrylic acids induced by application of safeners (substituted benzenesulfonamide herbicides), heat-shock promoters, a nitrate-inducible promoter derived from the spinach nitrate reductase transcribable nucleic acid molecule sequence, hormone-inducible promoters, and light-inducible promoters associated with the small subunit of RuBP carboxylase and LHCP families.
- tissue-specific, developmentally-regulated promoters examples include the ⁇ -conglycinin 7Sa promoter and seed-specific promoters.
- Plant functional promoters useful for preferential expression in seed plastid include those from proteins involved in fatty acid biosynthesis in oilseeds and from plant storage proteins.
- promoters include the 5' regulatory regions from such transcribable nucleic acid molecule sequences as phaseolin, napin, zein, soybean trypsin inhibitor, ACP, stearoyl-ACP desaturase, and oleosin.
- tissue-specific promoter is the lectin promoter, which is specific for seed tissue.
- promoters include the nopaline synthase, mannopine synthase, and octopine synthase promoters, which are carried on tumor-inducing plasmids of Agrobacterium tumefaciens; the cauliflower mosaic virus (CaMV) 19S and 35S promoters; the enhanced CaMV 35S promoter; the Figwort Mosaic Virus 35S promoter; the light-inducible promoter from the small subunit of ribulose-l,5-bisphosphate carboxylase (ssRUBISCO); the EIF-4A promoter from tobacco (Mandel et al, (1995) Plant Mol. Biol.
- CaMV cauliflower mosaic virus
- Figwort Mosaic Virus 35S promoter the light-inducible promoter from the small subunit of ribulose-l,5-bisphosphate carboxylase (ssRUBISCO)
- EIF-4A promoter from tobacco (Mandel et al, (1995) Plant Mol. Biol.
- corn sucrose synthetase corn alcohol dehydrogenase I; corn light harvesting compolex; corn heat shock protein; the chitinase promoter from Arabidopsis; the LTP (Lipid Transfer Protein) promoters; petunia chalcone isomerase; bean glycine rich protein 1 ; potato patatin; the ubiquitin promoter; and the actin promoter.
- Useful promoters are preferably seed-selective, tissue selective, or inducible. Seed-specific regulation is discussed in, for example, EP 0 255 378.
- Amino acid sequences according to some embodiments of the present invention show increasing percentage identities when aligned with SEQ ID NO:2.
- Specific amino acid sequences within these and other embodiments may comprise sequences having, for example, at least 70%, 75%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91 %, 92%, 93%, 94%, 95% 96%, 97%, 98%, or 100% identity with SEQ ID NO:2.
- aspects of the present invention concern novel genetically engineered desaturases derived from a parental castor desaturase.
- the genetically engineered desaturase is Com25.
- Com25 differs from the parental castor desaturase at the following 5 amino acid positions: Ml 14S, Tl 17R, LI 18C, P179L, and G188T (numbered according to the mature castor desaturase PDB entry 1 AFR).
- the genetically engineered desaturase may comprise one or more of these 5 mutations in Com25.
- a genetically engineered desaturase may differ from the parental castor desaturase at the following positions: Ml 14S; Tl 17R; LI 18C; P179L; G188T; Ml 14S and Tl 17R; Ml 14S and LI 18C; Ml 14S and P179L; Ml 14S and G188T; Tl 17R and LI 18C; Tl 17R and P179L; T117R and G188T; LI 18C and P179L; L118C and G188T; P179L and G188T;
- Ml 14S, Tl 17R, and LI 18C Ml 14S, Tl 17R, and P179L; Ml 14S, Tl 117R, and G188T; Ml 14S, LI 18C, and P179L; Ml 14S, LI 18C, and G188T; Ml 14S, P179L, and G188T; Tl 17R, LI 18C, and P179L; Tl 17R, LI 18C, and G188T; Tl 17R, P179L, and G188T; or L118C, P179L, and G188T.
- host cells or materials transformed with Com25 may exhibit increased levels of 16:0 fatty acids.
- Host cells may exhibit increased levels of 16:0 fatty acids, for example, by having metabolism of 16:0-ACP reduced in those host cells.
- Other methods of increasing levels of 16:0 fatty acids in a host cell may be used, and such methods may be chosen by the exercise of the discretion of one of skill in the art.
- Examples of methods of increasing levels of 16:0 fatty acids in a host cell include, but are not limited to: 1 ) expression of an extraplastidial desaturase in the host cell; 2) suppression of KASII in the host cell, for example by introducing a mutation in the fabl gene; and 3) decreasing elongation of 16:0 fatty acids, for example, by introducing a mutation in the fael gene.
- the present invention is also directed to methods of producing transformed cells which comprise one or more nucleic acid molecules comprising a nucleic acid sequence at least 60% identical to SEQ ID NO: 1.
- nucleic acid molecules may also comprise, for example, non-coding regulatory elements, such as promoters.
- Other sequences may also be introduced into the cell along with the non-coding regulatory elements and transcribable nucleic acid molecule sequences. These other sequences may include 3' transcriptional terminators, 3' poly-adenylation signals, other untranslated sequences, transit or targeting sequences, selectable markers, enhancers, and operators.
- the method of transformation generally comprises the steps of selecting a suitable host cell, transforming the host cell with a recombinant vector, and obtaining the transformed host cell.
- nucleic acids can be directly introduced into pollen by directly injecting a plant's reproductive organs (Zhou et al, (1983) Methods in Enzymology 101 :433; Hess (1987) Intern. Rev. Cytol. 107:367; Luo et al, (1988) Plant Mol. Biol. Reporter 6:165; Pena etal, (1987) Nature 325:274).
- Other transformation methods include, for example, protoplast transformation as illustrated in U.S. Patent No. 5,508,184.
- the nucleic acid molecules may also be injected into immature embryos (Neuhaus et al, (1987) Theor. Appl. Genet. 75:30).
- plant plastids may be transformed utilizing a microprojectile-mediated delivery of the desired nucleic acid molecule for certain plant species such as Arabidopsis, tobacco, potato and Brassica species.
- Agrobacterium-mediatQd transformation is achieved through the use of a genetically engineered soil bacterium belonging to the genus Agrobacterium.
- Several Agrobacterium species mediate the transfer of a specific DNA known as "T-DNA,” that can be genetically engineered to carry any desired piece of DNA into many plant species.
- T-DNA a specific DNA known as "T-DNA”
- the major events marking the process of T-DNA mediated pathogensis are: induction of virulence genes, and processing and transfer of TDNA. This process is the subject of many reviews (Ream (1989) Ann. Rev. Phytopathol. 27:583-618; Howard and Citovsky (1990) Bioassays 12:103-8; Kado (1991) Crit. Rev. Plant Sci. 10:1-32; Zambryski (1992) Annual Rev.
- the DNA introduced into the cell may contain a gene that functions in a regenerable plant tissue to produce a compound that confers upon the plant tissue resistance to an otherwise toxic compound.
- Genes of interest for use as a selectable, screenable, or scorable marker include, but are not limited to, GUS, green fluorescent protein (GFP), luciferase, and antibiotic or herbicide tolerance genes. Examples of antibiotic resistance genes include genes conferring resistance to the penicillins, kanamycin (and neomycin, G418, bleomycin); methotrexate (and trimethoprim);
- glyphosate resistance may be conferred by a herbicide resistance gene.
- Della-Cioppa et al (1987) Bio/Technology 5:579-84.
- Other selection devices can also be implemented including but not limited to tolerance to phosphinothricin, bialaphos, and positive selection mechanisms, Joersbro et al, (1998) Mol. Breed. 4: 111-7, and are considered within the scope of the present invention.
- the transformed cells identified by selection or screening and cultured in an appropriate medium that supports regeneration, may then be allowed to mature into plants.
- Transformable cells and tissues includes but is not limited to those cells or tissues that are capable of further propagation to give rise to a plant. Those of skill in the art recognize that a number of plant cells or tissues are
- Tissue suitable for these purposes can include but is not limited to immature embryos, scutellar tissue, suspension cell cultures, immature inflorescence, shoot meristem, nodal explants, callus tissue, hypocotyl tissue, cotyledons, roots, and leaves.
- the resulting transgenic rooted shoots are thereafter planted in an appropriate plant growth medium such as soil.
- Cells that survive the exposure to a selective agent, or cells that have been scored positive in a screening assay may be cultured in media that supports regeneration of plants.
- the shoots may then be transferred to an appropriate root-inducing medium containing the selective agent and an antibiotic to prevent bacterial growth. Many of the shoots will develop roots. These are then transplanted to soil or other media to allow the continued development of roots.
- the method as outlined above, will generally vary depending on the particular plant strain employed, and particulars of the methodology are therefore within the discretion of one of skill in the art.
- the regenerated transgenic plants may be self-pollinated to provide homozygous transgenic plants.
- pollen obtained from the regenerated transgenic plants may be crossed with non-transgenic plants, preferably inbred lines of agronomically important species.
- pollen from non-transgenic plants may be used to pollinate the regenerated transgenic plants.
- the transgenic plant may pass along the transformed nucleic acid sequence to its progeny.
- the transgenic plant is preferably homozygous for the transformed nucleic acid sequence and transmits that sequence to all of its offspring upon, and as a result of, sexual reproduction.
- Progeny may be grown from seeds produced by the transgenic plant. These additional plants may then be self-pollinated to generate a true breeding line of plants.
- the progeny from these plants may be evaluated, among other things, for gene expression.
- the gene expression may be detected by several common methods such as western blotting, northern blotting, immunoprecipitation, and ELIS A (Enzyme-Linked Immunosorbent Assay).
- the transformed plants may also be analyzed for the presence of the introduced DNA and the expression level and/or fatty acid profile conferred by the nucleic acid molecules and amino acid molecules of the present invention.
- methods for plant analysis include, but are not limited to, Southern blots or northern blots, PCR-based approaches, biochemical assays, phenotypic screening methods, field evaluations, and immunodiagnostic assays.
- Methods for specifically transforming dicots are well-known to those skilled in the art. Transformation and plant regeneration using these methods have been described for a number of crops including, but not limited to, members of the genus Arabidopsis, cotton (Gossypium hirsutum), soybean ⁇ Glycine max), peanut (Arachis hypogaea), and members of the genus Brassica. Methods for transforming dicots, primarily by use of Agrobacterium tumefaciens and obtaining transgenic plants have been published for cotton (U.S. Patent No. 5,004,863; U.S. Patent No. 5,159,135; U.S. Patent No. 5,518,908); soybean (U.S. Patent No.
- Transformation and plant regeneration using these methods have been described for a number of crops including, but not limited to, barley (Hordeum vulgarae); maize (Zea mays); oats (Avena sativa); orchard grass (Dactylis glomerata); rice (Oryza sativa, including indica and japonica varieties); sorghum (Sorghum bicolor); sugar cane (Saccharum sp); tall fescue (Festuca arundinacea); turfgrass species (e.g., Agrostis stolonifera, Poa pratensis, Stenotaphrum secundatum); wheat (Triticum aestivum); and alfalfa (Medicago sativa). It is apparent to those of skill in the art that a number of transformation methodologies can be used and modified for production of stable transgenic plants for any number of target crops of interest.
- Any plant may be chosen for use in the presently disclosed methods.
- Preferred plants for modification according to the present invention include Arabidopsis thaliana, borage (Borago spp.), Canola, castor (Ricinus communis), cocoa bean
- Tropaeolum spp. Oenothera spp., olive (Olea spp.), palm (Elaeis spp.), peanut (Arachis spp.), rapeseed, safflower (Carthamus spp.), soybean (Glycine and Soja spp.), sunflower (Helianthus spp.), tobacco (Nicotiana spp.), Vernonia spp., wheat (Triticum spp.), barley (Hordeum spp.), rice (Oryza spp.), oat (Avena spp.) sorghum (Sorghum spp.), rye (Secale spp.) or other members of the Gramineae.
- a transgenic seed comprises a polypeptide comprising an amino acid sequence at least 90% identical to SEQ ID NO:2.
- the transgenic seed comprises a nucleic acid sequence at least 60%» identical to SEQ ID NO: 1.
- the seeds of the present invention exhibit increased levels of unusual fatty acids, for example, co-7 fatty acids, such as 16:1 ⁇ 19 and/or 18:1 ⁇ ⁇ .
- the seeds can be harvested from fertile transgenic plants and be used to grow progeny generations of transformed plants of this invention, including hybrid plant lines comprising a nucleic acid sequence according to this invention and another gene or nucleic acid construct of interest.
- X5 LEDTM flashlight Inova
- Com25 is a variant of the Ricinus communis A -18:0-ACP desaturase that arose from a program of combinatorial saturation mutagenesis/selection designed to identify variants with improved activity towards acyl chains of less than 18C in lengths.
- Com25 differs from the parental castor desaturase at the following 5 amino acid positions: Ml 14S, Tl 17R,
- Phas Com25.
- the entire open reading frame of the castor variant Com25, engineered to contain its authentic transit peptide and flanked by 5' Pad and 3' Xhol restriction sites was cloned into the corresponding sites of plasmid pDs-Red-Phas, Pidkowich et al, (2007) Proc. Natl. Acad. Sci. USA 104(11): 4742-7, (with Ds-Red marker) to create P as:Com25 (FIG. 5).
- LTP170 promoter was amplified from Arabidopsis genomic DNA using primers P17-5'BamHI
- a fragment containing Com25 along with the phaseolin terminator was excised using BamHI and EcoRV and cloned into the BamHI and Smal restriction sites within vector pDs-Red-LTP170-Com25 to create
- V as-.Fabl-HPAS This construct was created in two steps; first the construction of V s&:FatB-HP , and afterwards the insertion of an antisense portion of the FatB gene to replace part of the Fad2 intron separating the sense and antisense portions of the FatB gene comprising the hairpin.
- 150 bp of the Arabidopsis FatB 3'UTR was amplified from genomic DNA in both sense (using primers FatB-hps-5'PstI GGGCTGCAGAAACAAGTTTCGGCCACCAACC C; SEQ ID NO:5 and FatB-hps-3'XhoI CCCCTCGAGACATCAGAATTCGTAATGAT; SEQ ID NO: 6) and antisense (using primers FatB-hpa-5'NheI
- FatB-Exon-5'Sp-Bam (CCACTAGTGGATCCACCTCTGCTACGTCGTCATT; SEQ ID NO:9) and FatB-Exon-3'Bg-Sal
- pCVMV:Ds-Red had been replaced by a green fluorescent protein marker
- Phas:AnD9d Phas:LnD9D.
- Two fungal acyl-CoA D9 desaturases were combined in plasmid pDAB7318 with both genes being driven by the seed-specific Phas promoter from Phaseolus vulgaris.
- the first gene in the construct was an acyl-CoA A9-desaturase from Aspergillus nidulans that was redesigned and
- A9-desaturase from Leptosphaeria nodorum that was also redesigned and synthesized for plant expression and fused to the Agrobacterium tumefaciens ORF23 3' untranslated region.
- This desaturase was identified by homology searches of the S. nodorum genome sequence released by the Leptosphaeria nodorum Sequencing Project, Broad Institute of Harvard and MIT (http://www.broad.mit.edu). It was shown to have a preference for desaturation of palmitate by complementation of the olel mutant of Saccharomyces cerevisiae. Phas:i3 ⁇ 4W-HPAS-Phas:Com25.
- plasmid Phas: W/HPAS-Phas:Com25 was constructed to combine Com25 expression with KASII suppression.
- the Phaseolin terminator was isolated from Phas :Com25 and cloned into the intermediate vector pBL, with the EcoRV-EcoRV fragment containing the Phaseolin promoter driving Com25, to create pBL-Phas:Com25-PhasTer.
- This Com25 expression cassette was excised using flanking EcoRI-EcoRI restriction sites and cloned into the corresponding site within Phas:i3 ⁇ 4W-HPAS to create Phas:FaW-HPAS-Phas-Com25. See FIG. 5.
- FAMEs fatty-acid methyl esters
- FAMEs fatty-acid methyl esters
- FAMEs were prepared by incubating the seeds in 0.5 n L BC1 3 for 1 h at 80°C, extracting them with 1 mL hexane, and then drying under N 2 .
- FAMEs were analyzed either with an HP6890TM gas chromatograph-flame ionization detector (Agilent Technologies), or an HP5890TM gas chromatograph-mass spectrometer
- Table 1 shows that while Com25 has a much improved kc at (11.1 min "1 ) over castor WT (2.8 min ') for 16:0-ACP substrate, it falls short of that reported for castor variant 5.2 (25.3 min-1). Whittle and Shanklin (2001) J. Biol. Chem. 276(24):21500-5. However, Com25's K m for 16:0-ACP (0.12 ⁇ ) is 4.6-times lower than that of castor variant 5.2 (0.55) and 42-times lower than that of castor WT (5.0). The resulting specificity factor with 16:0-ACP substrate for com25 of 91 ⁇ "1 ⁇ min 1 is
- Com25's specificity factor with 16:0-ACP is equivalent to that of castor WT with its natural 18:0-ACP substrate (92 ⁇ "1 ⁇ min "1 ).
- Com25's improved K m for 16:0-ACP relative to castor variant 5.2 suggests it completes more effectively with FatB and KASII for substrate, providing an explanation as to why its expression facilitates greater accumulation of co-7 FA than castor variant 5.2, despite its lower K cat .
- Example IV Expression of Com25 in hosts containing increased levels of 16:0
- fatty acids are synthesized de novo via the ACP track to a first branch point at the level of 16:0- ACP.
- FIG. 1 If acted on by FATB, the palmitoyl thioesterase, 16:0 free fatty acid is released from the plastid to the cytoplasm where it is esterified to CoA, and subsequently transesterified onto phospholipids of the endomembrane system.
- ⁇ -ketoacyl-ACP synthase II elongates the majority of 16:0-ACP to 18:0-ACP whereupon it is desaturated by the
- a 9 -stearoyl-ACP desaturase to produce oleoyl-ACP.
- FATA the oleoyl-ACP thioesterase releases the oleic acid, which exits the plastid and, like the palmitate, becomes activated to the CoA-thioester and is transferred to the phospholipids.
- oleate can be elongated to 10:1 ⁇ ⁇ via the action of the fatty acid elongase (FAE) I, or become sequentially desaturated by the action of FAD2 and FAD3 to produce linolenic or linolenic acids respectively.
- FAE fatty acid elongase
- 16:0- ACP is the earliest metabolite in the FA synthesis pathway that can be committed to co-7 production by its desaturation to 16:1A 9 -ACP.
- FIG.1 (reaction 1) the feasibility of expressing a plastidial A 9 -16:0-ACP-specific desaturase under the control of a seed-specific promoter was explored.
- FIG. 2 shows representative GC traces of seed FA methyl esters.
- Apple Genet. 80:241-45 that exhibits increased 16:0 levels in leaves and seeds, which contain about 21% of 16:0 compared to about 10% in WT, as shown in FIG.2C; and Table 2.
- Biochemical evidence showed that the fabl lesion is in KASII, because its activity was reduced in the mutant.
- Example V Increasing Com25 gene dosage results in increased ⁇ -7
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Developmental Biology & Embryology (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2016010612A MX355329B (en) | 2010-06-24 | 2011-06-24 | Accumulation of omega-7 fatty acids in plant seeds. |
PL11798970T PL2585599T3 (en) | 2010-06-24 | 2011-06-24 | Accumulation of omega-7 fatty acids in plant seeds |
ES11798970.7T ES2645239T3 (en) | 2010-06-24 | 2011-06-24 | Accumulation of Omega-7 fatty acids in plant seeds |
EP11798970.7A EP2585599B1 (en) | 2010-06-24 | 2011-06-24 | Accumulation of omega-7 fatty acids in plant seeds |
UAA201300815A UA113834C2 (en) | 2010-06-24 | 2011-06-24 | METHOD OF INCREASING THE NUMBER OF NON-PROPER FATTY ACIDS IN VEGETABLE MATERIAL |
JP2013516790A JP6068336B2 (en) | 2010-06-24 | 2011-06-24 | Accumulation of omega-7 fatty acids in plant seeds |
EA201291242A EA022985B1 (en) | 2010-06-24 | 2011-06-24 | Accumulation of omega-7 fatty acids in plant seeds |
NZ603968A NZ603968A (en) | 2010-06-24 | 2011-06-24 | Accumulation of omega-7 fatty acids in plant seeds |
BR112012033037A BR112012033037A2 (en) | 2010-06-24 | 2011-06-24 | accumulation of omega 7 fatty acids in vegetable seeds. |
MX2012015291A MX343272B (en) | 2010-06-24 | 2011-06-24 | Accumulation of omega-7 fatty acids in plant seeds. |
AU2011270751A AU2011270751B2 (en) | 2010-06-24 | 2011-06-24 | Accumulation of omega-7 fatty acids in plant seeds |
KR1020137001833A KR20130026487A (en) | 2010-06-24 | 2011-06-24 | Accumulation of omega-7 fatty acids in plant seeds |
CA2803599A CA2803599C (en) | 2010-06-24 | 2011-06-24 | Accumulation of omega-7 fatty acids in plant seeds |
CN201180031133.XA CN103429741B (en) | 2010-06-24 | 2011-06-24 | Accumulation of omega-7 fatty acids in plant seeds |
ZA2012/09082A ZA201209082B (en) | 2010-06-24 | 2012-11-30 | Accumulation of omega-7 fatty acids in plant seeds |
IL223440A IL223440A (en) | 2010-06-24 | 2012-12-04 | Accumulation of omega-7 fatty acids in plant seeds |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35831810P | 2010-06-24 | 2010-06-24 | |
US61/358,318 | 2010-06-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011163557A2 true WO2011163557A2 (en) | 2011-12-29 |
WO2011163557A3 WO2011163557A3 (en) | 2012-04-19 |
Family
ID=45353924
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2011/041759 WO2011163557A2 (en) | 2010-06-24 | 2011-06-24 | Accumulation of omega-7 fatty acids in plant seeds |
Country Status (21)
Country | Link |
---|---|
US (2) | US9340776B2 (en) |
EP (1) | EP2585599B1 (en) |
JP (1) | JP6068336B2 (en) |
KR (1) | KR20130026487A (en) |
CN (1) | CN103429741B (en) |
AR (1) | AR081302A1 (en) |
AU (1) | AU2011270751B2 (en) |
BR (1) | BR112012033037A2 (en) |
CA (1) | CA2803599C (en) |
CL (1) | CL2012003663A1 (en) |
EA (1) | EA022985B1 (en) |
ES (1) | ES2645239T3 (en) |
HU (1) | HUE037067T2 (en) |
IL (1) | IL223440A (en) |
MX (2) | MX343272B (en) |
NZ (1) | NZ603968A (en) |
PL (1) | PL2585599T3 (en) |
TW (1) | TWI570239B (en) |
UA (1) | UA113834C2 (en) |
WO (1) | WO2011163557A2 (en) |
ZA (1) | ZA201209082B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170098810A (en) * | 2014-12-19 | 2017-08-30 | 다우 아그로사이언시즈 엘엘씨 | Generation of transgenic canola with low or no saturated fatty acids |
CN105053256A (en) * | 2015-07-29 | 2015-11-18 | 广州金酮医疗科技有限公司 | Flavored nutrition balanced blend oil |
CN114431101B (en) * | 2022-01-28 | 2023-02-28 | 广西壮族自治区农业科学院 | Sugarcane 13 Method and device for marking C isotope |
Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0255378A2 (en) | 1986-07-31 | 1988-02-03 | Calgene, Inc. | Seed specific transcriptional regulation |
US5004863A (en) | 1986-12-03 | 1991-04-02 | Agracetus | Genetic engineering of cotton plants and lines |
US5384253A (en) | 1990-12-28 | 1995-01-24 | Dekalb Genetics Corporation | Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes |
US5416011A (en) | 1988-07-22 | 1995-05-16 | Monsanto Company | Method for soybean transformation and regeneration |
US5463174A (en) | 1986-05-29 | 1995-10-31 | Calgene Inc. | Transformation and foreign gene expression in Brassica species |
US5508184A (en) | 1986-12-05 | 1996-04-16 | Ciba-Geigy Corporation | Process for transforming plant protoplast |
US5518908A (en) | 1991-09-23 | 1996-05-21 | Monsanto Company | Method of controlling insects |
US5538880A (en) | 1990-01-22 | 1996-07-23 | Dekalb Genetics Corporation | Method for preparing fertile transgenic corn plants |
US5550318A (en) | 1990-04-17 | 1996-08-27 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
US5591616A (en) | 1992-07-07 | 1997-01-07 | Japan Tobacco, Inc. | Method for transforming monocotyledons |
US5981840A (en) | 1997-01-24 | 1999-11-09 | Pioneer Hi-Bred International, Inc. | Methods for agrobacterium-mediated transformation |
US6160208A (en) | 1990-01-22 | 2000-12-12 | Dekalb Genetics Corp. | Fertile transgenic corn plants |
US6384301B1 (en) | 1999-01-14 | 2002-05-07 | Monsanto Technology Llc | Soybean agrobacterium transformation method |
US6399861B1 (en) | 1990-04-17 | 2002-06-04 | Dekalb Genetics Corp. | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
US6403865B1 (en) | 1990-08-24 | 2002-06-11 | Syngenta Investment Corp. | Method of producing transgenic maize using direct transformation of commercially important genotypes |
US20080260933A1 (en) | 2004-10-08 | 2008-10-23 | Dow Agroscience Llc | Certain Plants with "No Saturate" or Reduced Saturate Levels of Fatty Acids in Seeds, and Oil Derived from the Seeds |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2084348A1 (en) * | 1991-12-31 | 1993-07-01 | David F. Hildebrand | Fatty acid alteration by a d9 desaturase in transgenic plant tissue |
US7109392B1 (en) * | 1996-10-09 | 2006-09-19 | Cargill, Incorporated | Methods for increasing oleic acid content in seeds from transgenic plants containing a mutant delta 12 desaturase |
US7323335B2 (en) * | 1999-01-19 | 2008-01-29 | Brookhaven Science Associates, Llc | Mutant fatty acid desaturase and methods for directed mutagenesis |
EP1214334B1 (en) | 1999-06-09 | 2006-10-11 | Brookhaven Science Associates LLC | Mutant fatty acid desaturase |
US7214859B2 (en) * | 2002-08-16 | 2007-05-08 | National Research Council Of Canada | Brassica pyruvate dehydrogenase kinase gene |
US7655833B2 (en) * | 2003-05-29 | 2010-02-02 | Brookhaven Science Associates, Llc | ADS genes for reducing saturated fatty acid levels in seed oils |
US7122367B2 (en) * | 2003-06-03 | 2006-10-17 | Board Of Trustees Operating Michigan State University | Diacylglycerol acyltransferase genes, proteins, and uses thereof |
EP2338328B1 (en) | 2004-10-08 | 2017-09-20 | Dow AgroSciences LLC | Certain plants with no saturate or reduced saturate levels of fatty acids in seeds, and oil derived from the seeds |
AU2006312126A1 (en) * | 2005-11-04 | 2007-05-18 | Dow Agrosciences Llc | Preparation of vaccine master cell lines using recombinant plant suspension cultures |
US7943823B2 (en) * | 2006-04-28 | 2011-05-17 | E.I. Du Pont De Nemours And Company | Delta-8 desaturase and its use in making polyunsaturated fatty acids |
US8957280B2 (en) * | 2007-05-03 | 2015-02-17 | E. I. Du Pont De Nemours And Company | Delta-5 desaturases and their use in making polyunsaturated fatty acids |
-
2011
- 2011-06-23 AR ARP110102187A patent/AR081302A1/en unknown
- 2011-06-23 TW TW100122017A patent/TWI570239B/en not_active IP Right Cessation
- 2011-06-24 CA CA2803599A patent/CA2803599C/en active Active
- 2011-06-24 UA UAA201300815A patent/UA113834C2/en unknown
- 2011-06-24 ES ES11798970.7T patent/ES2645239T3/en active Active
- 2011-06-24 WO PCT/US2011/041759 patent/WO2011163557A2/en active Application Filing
- 2011-06-24 JP JP2013516790A patent/JP6068336B2/en not_active Expired - Fee Related
- 2011-06-24 PL PL11798970T patent/PL2585599T3/en unknown
- 2011-06-24 KR KR1020137001833A patent/KR20130026487A/en active IP Right Grant
- 2011-06-24 HU HUE11798970A patent/HUE037067T2/en unknown
- 2011-06-24 EP EP11798970.7A patent/EP2585599B1/en not_active Not-in-force
- 2011-06-24 EA EA201291242A patent/EA022985B1/en not_active IP Right Cessation
- 2011-06-24 MX MX2012015291A patent/MX343272B/en active IP Right Grant
- 2011-06-24 AU AU2011270751A patent/AU2011270751B2/en active Active
- 2011-06-24 BR BR112012033037A patent/BR112012033037A2/en not_active IP Right Cessation
- 2011-06-24 CN CN201180031133.XA patent/CN103429741B/en not_active Expired - Fee Related
- 2011-06-24 NZ NZ603968A patent/NZ603968A/en not_active IP Right Cessation
- 2011-06-24 US US13/168,320 patent/US9340776B2/en not_active Expired - Fee Related
- 2011-06-24 MX MX2016010612A patent/MX355329B/en unknown
-
2012
- 2012-11-30 ZA ZA2012/09082A patent/ZA201209082B/en unknown
- 2012-12-04 IL IL223440A patent/IL223440A/en active IP Right Grant
- 2012-12-21 CL CL2012003663A patent/CL2012003663A1/en unknown
-
2016
- 2016-04-15 US US15/130,788 patent/US9976155B2/en active Active
Patent Citations (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5463174A (en) | 1986-05-29 | 1995-10-31 | Calgene Inc. | Transformation and foreign gene expression in Brassica species |
EP0255378A2 (en) | 1986-07-31 | 1988-02-03 | Calgene, Inc. | Seed specific transcriptional regulation |
US5004863B2 (en) | 1986-12-03 | 2000-10-17 | Agracetus | Genetic engineering of cotton plants and lines |
US5004863A (en) | 1986-12-03 | 1991-04-02 | Agracetus | Genetic engineering of cotton plants and lines |
US5159135A (en) | 1986-12-03 | 1992-10-27 | Agracetus | Genetic engineering of cotton plants and lines |
US5004863B1 (en) | 1986-12-03 | 1992-12-08 | Agracetus | |
US5159135B1 (en) | 1986-12-03 | 2000-10-24 | Agracetus | Genetic engineering of cotton plants and lines |
US5508184A (en) | 1986-12-05 | 1996-04-16 | Ciba-Geigy Corporation | Process for transforming plant protoplast |
US5416011A (en) | 1988-07-22 | 1995-05-16 | Monsanto Company | Method for soybean transformation and regeneration |
US5569834A (en) | 1988-07-22 | 1996-10-29 | Monsanto Company | Method for soybean transformation and regeneration |
US5824877A (en) | 1988-07-22 | 1998-10-20 | Monsanto Company | Method for soybean transformation and regeneration |
US5538880A (en) | 1990-01-22 | 1996-07-23 | Dekalb Genetics Corporation | Method for preparing fertile transgenic corn plants |
US6160208A (en) | 1990-01-22 | 2000-12-12 | Dekalb Genetics Corp. | Fertile transgenic corn plants |
US6399861B1 (en) | 1990-04-17 | 2002-06-04 | Dekalb Genetics Corp. | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
US5550318A (en) | 1990-04-17 | 1996-08-27 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
US6403865B1 (en) | 1990-08-24 | 2002-06-11 | Syngenta Investment Corp. | Method of producing transgenic maize using direct transformation of commercially important genotypes |
US5384253A (en) | 1990-12-28 | 1995-01-24 | Dekalb Genetics Corporation | Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes |
US5518908A (en) | 1991-09-23 | 1996-05-21 | Monsanto Company | Method of controlling insects |
US5591616A (en) | 1992-07-07 | 1997-01-07 | Japan Tobacco, Inc. | Method for transforming monocotyledons |
US5981840A (en) | 1997-01-24 | 1999-11-09 | Pioneer Hi-Bred International, Inc. | Methods for agrobacterium-mediated transformation |
US6384301B1 (en) | 1999-01-14 | 2002-05-07 | Monsanto Technology Llc | Soybean agrobacterium transformation method |
US20080260933A1 (en) | 2004-10-08 | 2008-10-23 | Dow Agroscience Llc | Certain Plants with "No Saturate" or Reduced Saturate Levels of Fatty Acids in Seeds, and Oil Derived from the Seeds |
Non-Patent Citations (81)
Title |
---|
; TATIANA ET AL., FEMS MICROBIOL. LETT., vol. 174, 1990, pages 247 - 50 |
ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 10 |
BINNS; HOWITZ: "Bacterical Pathogenesis of Plants and Animals", 1994, SPRINGER VERLAG., pages: 119 - 38 |
BONDARUK ET AL., PLANT BREEDING, vol. 126, 2007, pages 186 - 94 |
BROUN ET AL., PLANT JOURNAL, vol. 13, 1997, pages 201 - 10 |
BROUN; SOMERVILLE, PLANT PHYSIOL., vol. 113, 1997, pages 933 - 42 |
BURGAL ET AL., PLANT BIOTECHNOL. J., vol. 6, no. 8, 2008, pages 819 - 31 |
BUTTE ET AL., ANAL. LETT, vol. 15, no. 10, 1982, pages 841 - 50 |
CAHOON ET AL., PLANT MOL. BIOL, vol. 33, 1997, pages 1105 - 10 |
CAHOON ET AL., PLANT MOL. BIOL., vol. 33, 1997, pages 1105 - 10 |
CAHOON ET AL., PLANT PHYSIOL., vol. 117, no. 2, 1998, pages 593 - 8 |
CAHOON ET AL., PROG. LIPID RES., vol. 33, 1994, pages 155 - 63 |
CAPECHI, CELL, vol. 22, no. 2, 1980, pages 479 - 88 |
CARLSSON ET AL., PLANT J., vol. 29, no. 6, 2002, pages 761 - 70 |
CHAU ET AL., SCIENCE, vol. 244, 1989, pages 174 - 81 |
CHENG ET AL., PLANT CELL REP, vol. 15, 1996, pages 653 - 7 |
CHISHOLM; HOPKINS, J. AM. OIL CHEM. SOC, vol. 42, 1965, pages 49 - 50 |
CHRISTOU ET AL., PLANT PHYSIOL., vol. 87, 1988, pages 671 - 4 |
CLAPP, CLIN. PERINATOL, vol. 20, no. 1, 1993, pages 155 - 68 |
CLOUGH; BENT, PLANT J., vol. 16, no. 6, 1998, pages 735 - 43 |
CORPET ET AL., NUCLEIC ACIDS RESEARCH, vol. 16, 1988, pages 10881 - 10890 |
CURIEL ET AL., HUM. GEN. THER., vol. 3, no. 2, 1992, pages 147 - 54 |
DELLA-CIOPPA ET AL., BIO/TECHNOLOGY, vol. 5, 1987, pages 579 - 84 |
EGLITIS; ANDERSON, BIOTECHNIQUES, vol. 6, no. 7, 1988, pages 608 - 14 |
FRALEY ET AL., PROC. NATL. ACAD. SCI. USA, vol. 80, 1983, pages 4803 |
FRALEY ET AL., PROC. NATL. ACAD. SCI. USA, vol. 80, 1993, pages 4803 |
FROMM ET AL., PROC. NATL. ACAD. SCI. USA, vol. 82, no. 17, 1985, pages 5824 - 8 |
FYNAN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 90, no. 24, 1993, pages 11478 - 82 |
GELVIN: "Transgenic Plants", 1993, ACADEMIC PRESS, pages: 49 - 87 |
GOLDSTEIN: "Protein Folding, Evolution and Design", vol. CXLIV, 2001, I.O.S. PRESS |
GOVINDARAJAN; GOLDSTEIN, PROC. NATL. ACAD. SCI. USA, vol. 95, 1998, pages 5545 - 49 |
GRAHAM; VAN DER EB, VIROLOGY, vol. 54, no. 2, 1973, pages 536 - 9 |
GRANT ET AL., PLANT CELL REP., vol. 15, 1995, pages 254 - 8 |
HESS, INTERN. REV. CYTOL., vol. 107, 1987, pages 367 |
HIGGINS; SHARP, CABIOS, vol. 5, 1989, pages 151 - 3 |
HIGGINS; SHARP, GENE, vol. 73, 1988, pages 237 - 44 |
HOOYKAAS; BEIJERSBERGEN, ANN. REV. PHYTOPATHOL, vol. 32, 1994, pages 157 - 79 |
HOPKINS; CHISHOLM, CAN. J. BIOCHEM. PHYSIOL., vol. 39, 1961, pages 829 - 35 |
HORSCH ET AL., SCIENCE, vol. 227, 1985, pages 1229 - 31 |
HOWARD; CITOVSKY, BIOASSAYS, vol. 12, 1990, pages 103 - 8 |
HUANG ET AL., COMPUTER APPLICATIONS IN THE BIOSCIENCES, vol. 8, 1992, pages 155 - 65 |
JAMES; DOONER, THEOR. APPLE GENET, vol. 80, 1990, pages 241 - 45 |
JOERSBRO ET AL., MOL. BREED., vol. 4, 1998, pages 111 - 7 |
JOHNSTON; TANG, METHODS CELL BIOL., vol. 43, no. A, 1994, pages 353 - 65 |
KADO, CRIT. REV. PLANT SCI, vol. 10, 1991, pages 1 - 32 |
KNUTZON ET AL., PLANT PHYSIOL., vol. 120, no. 3, 1999, pages 739 - 46 |
LEE ET AL., SCIENCE, vol. 280, no. 5365, 1998, pages 915 - 18 |
LESSL; LANKA, CELL, vol. 77, 1994, pages 321 - 4 |
LU ET AL., J. EXP. MED., vol. 178, no. 6, 1993, pages 2089 - 96 |
LUO ET AL., PLANT MOL. BIOL. REPORTER, vol. 6, 1988, pages 165 |
MANDEL ET AL., PLANT MOL. BIOL., vol. 29, 1995, pages 995 - 1004 |
MCCABE ET AL., BIOTECHNOLOGY, vol. 6, 1988, pages 923 |
MCKENTLY ET AL., PLANT CELL REP, vol. 14, 1995, pages 699 - 703 |
NAPIER, J.A., ANNU. REV. PLANT BIOL, vol. 58, 2007, pages 295 - 319 |
NAPIER, J.A., ANNU. REV. PLANT BIOL., vol. 58, 2007, pages 295 - 319 |
NEEDLEMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443 |
NEUHAUS ET AL., THEOR. APPL. GENET, vol. 75, 1987, pages 30 |
NGUYEN; SHANKLIN, JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY, vol. 86, 2009, pages 41 - 9 |
ODELL ET AL., NATURE, vol. 313, 1985, pages 810 |
PEARSON ET AL., METHODS IN MOLECULAR BIOLOGY, vol. 24, 1994, pages 307 - 31 |
PEARSON; LIPMAN, PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 2444 |
PENA ET AL., NATURE, vol. 325, 1987, pages 274 |
PIDKOWICH ET AL., PROC. NATL. ACAD. SCI. USA, vol. 104, no. 11, 2007, pages 4742 - 7 |
POSZKOWSKI ET AL., EMBO J., vol. 3, 1989, pages 2719 |
REAM, ANN. REV. PHYTOPATHOL., vol. 27, 1989, pages 583 - 618 |
See also references of EP2585599A4 |
SHOCKEY ET AL., PLANT PHYSIOL., vol. 132, no. 2, 2003, pages 1065 - 76 |
SLIGHTOM ET AL., PROC. NATL. ACAD. SCI. USA, vol. 80, no. 7, 1983, pages 1897 - 1901 |
SMITH; WATERMAN, ADV. APPL. MATH., vol. 2, 1981, pages 482 |
STUITJE ET AL., PLANT BIOTECHNOL. J., vol. 1, no. 4, 2003, pages 301 - 9 |
VAN DER GEEST; HALL, PLANT MOL BIOL., vol. 33, no. 3, 1997, pages 553 - 7 |
WAGNER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 89, no. 13, 1992, pages 6099 - 103 |
WEISSBACH; WEISSBACH: "Methods for Plant Molecular Biolog", 1988, ACADEMIC PRESS, INC. |
WHITTLE; SHANKLIN, J. BIOL. CHEM, vol. 276, no. 24, 2001, pages 21500 - 5 |
WHITTLE; SHANKLIN, J. BIOL. CHEM., vol. 276, no. 24, 2001, pages 21500 - 5 |
WONG; NEUMANN, BIOCHIM. BIOPHYS. RES. COMMUN., vol. 107, no. 2, 1982, pages 584 - 7 |
YAMAMOTO ET AL., CHEM. AND PHYS. LIPIDS, vol. 60, no. 1, 1991, pages 39 - 50 |
ZAMBRYSKI, ANNUAL REV. PLANT PHYSIOL. PLANT MOL. BIOL., vol. 43, 1992, pages 465 - 90 |
ZATLOUKAL ET AL., ANN. N.Y. ACAD. SCI, vol. 660, 1992, pages 136 - 53 |
ZHOU ET AL., METHODS IN ENZYMOLOGY, vol. 101, 1983, pages 433 |
ZUPAN; ZAMBRYSKI, ANNUAL REV. PHYTOPATHOL., vol. 27, 1995, pages 583 - 618 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2803098C (en) | Lowering saturated fatty acid content of plant seeds | |
WO2016099568A1 (en) | Generation of transgenic canola with low or no saturated fatty acids | |
US9976155B2 (en) | Accumulation of omega-7 fatty acids in plant seeds | |
AU2023241326A1 (en) | Enzymes and methods for producing omega-3 fatty acids | |
US10370674B2 (en) | Generation of transgenic canola with low or no saturated fatty acids | |
AU2015201328B2 (en) | Lowering saturated fatty acid content of plant seeds | |
US20170145433A1 (en) | Lowering saturated fatty acid content of plant seeds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11798970 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 223440 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 201291242 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2012/015291 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2803599 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2013516790 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012003663 Country of ref document: CL |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2011270751 Country of ref document: AU Date of ref document: 20110624 Kind code of ref document: A |
|
REEP | Request for entry into the european phase |
Ref document number: 2011798970 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011798970 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 20137001833 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: A201300815 Country of ref document: UA |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112012033037 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112012033037 Country of ref document: BR Kind code of ref document: A2 Effective date: 20121221 |